Skip to main content

Yu de laf wantɛm wantɛm fɔ natin? Yu de kam kray? Dis kin bi Pseudobulbar Afɛkt (PBA) .

Yu de laf wantɛm wantɛm fɔ natin? Yu de kam kray? Dis kin bi Pseudobulbar Afɛkt (PBA) .

Imajin if yu jɔs sidɔm de, ɔ tɔk bɔt sɔntin we de mek yu at pwɛl smɔl, ɛn yu bigin fɔ laf lawd wan we yu nɔ ebul kɔntrol? Ɔ if yu bigin kray so dat yu nɔ go ebul fɔ stɔp ivin we yu jok smɔl? Pan ɔl we dis kin tan lɛk se i strenj smɔl, fɔ tru, na sik we pɔsin kin gɛt we i de mɛn pipul dɛn. Dis nɔto wikɛd tin na yu maynd ɔ sɔntin we kray. Tide wi de tɔk bɔt dis strenj, bɔt wan we kin afɛkt bɔku pipul dɛn.

Fɔ tɔk am simpul wan, wetin na Pseudobulbar Affect (PBA)?

Pseudobulbar affect (PBA) na wan kכndyushכn we de afekt di nεv sεstem. I kin bi se pɔsin nɔ ebul fɔ kɔntrol am, ɔ i nɔ fayn fɔ laf ɔ kray. Di impɔtant tin na fɔ mek dis laf ɔ kray nɔ gri wit di we aw yu de fil insay yu at . Dis min se yu kin kray we yu nɔ ebul fɔ kɔntrol yusɛf ilɛksɛf yu nɔ de fil bad insay yu at. Semweso, yu kin laf we yu nɔ ebul kɔntrol ilɛksɛf natin nɔ de fɔ laf.

Dis kכndyushכn kin apin as a rizulεt fכ damej pan di bren כ as sayd ifekt fכ כda nyurolכjik kכndyushכn. fכ egzampl, yu kin si am wit wan kכndishכn lεk `(Amyotrophic Lateral Sclerosis - ALS)`.

Pan ɔl we sɔmtɛm dis laf ɔ kray kin tan lɛk se i fayn da tɛm de (fɔ ɛgzampul, fɔ kray we yu si sɔntin we sɔri), i kin rili at fɔ mek pɔsin we gɛt PBA kɔntrol am. Ɛn di we aw dɛn de sho dɛn filin ya kin rili tranga ɛn i kin te pas aw pɔsin kin fil.

Dɛn kin kɔl dis kɔndishɔn sɔm ɔda nem dɛn:

  • Imɔshɔnal labiliti
  • Pathological laf ɛn kray
  • Dizayd fɔ sho aw pɔsin de fil we i nɔ want
  • Fɔ laf ɔ kray we pɔsin kin fos fɔ du
  • I nɔ kin ebul fɔ kɔntrol insɛf pan di we aw pɔsin de fil

PBA kin rili afɛkt yu layf, yu famili, ɛn di wan dɛn we de kia fɔ yu. I kin mek pɔsin shem, wɔri, fɔ lɛf fɔ it, ɛn ivin fɔ mek i nɔ de nia ɔda pipul dɛn.

Aw kɔmɔn dis kɔndishɔn, PBA? Udat kin gɛt am?

E tranga fɔ tɔk ustɛm dis kin bi, bikɔs de kayn sik wae de kam pan dis sik kin difrɛn frɔm pɔrsin to ɔda pɔrsin. Dɔn bak, bɔrku tɛm dɛn kin misdiagnose am as ɔda sik, mɔr lɛk pwɛl hat.

PBA kin apin pan ɛnibɔdi we gɛt ɛni ej, ivin pikin ɛn big pipul, we gɛt ɔda sik we gɛt fɔ du wit dɛn bren.

As di mɛdikal stɔdi dɛn dɔn sho:

  • כp to 50% pan di pipul dεm we gεt amyotrophic lateral sclerosis (ALS) kin gεt PBA.
  • Dis kכndyushכn kin apun to 48% pan di pipul dεm wae dεn gεt traumatik bren injuri.
  • te to 46% pan di pipul dεm we gεt mכltipכl sklεrosis (MS) kin gεt PBA.

So yu tink se dis na mental sik?

Bɔrku pipul kin tink bɔt am as maynd sik bikɔs na do kin gɛt fɔ du wit filin lɛk fɔ laf ɛn kray. Bɔt fɔ tru, i nɔto mental sik atɔl.

Fɔ tɔk strikt wan, PBA na nyurosaykayatrik sindrom . Fɔ tɔk am simpul wan, na kɔndishɔn we yu nɔ kin ebul fɔ kɔntrol yu filin bikɔs di nyural sɔrkwit dɛn na yu bren dɔn pwɛl. So e kin kɔrɛkt fɔ tink bɔt am as bɔdi prɔblɛm we gɛt fɔ du wit di bren pas fɔ tink bɔt am as prɔblɛm wit yu maynd.

Wetin na di men sayn dɛm fɔ PBA?

fכ כndastand PBA, wi nid fכ no di difrεns bitwin ‘mud’ εn ‘afεkt’.

  • Di we aw yu de fil: Dis de tɔk bɔt aw yu de fil insay yu at. Dat min se di filin dɛn we yu kin fil insay yu at, lɛk fɔ fil bad, fɔ gladi, ɛn fɔ vɛks. Dis na sɔntin we na yu nɔmɔ go ebul fɔ fil.
  • Affect: Dis na aw yu de sho aw yu de fil na do. Dat min tin dɛn lɛk fɔ smayl, kray, ɛn fɔ sho aw ɔda pipul dɛn de si in fes.

So, di men tin we PBA gɛt na dat yu ‘afɛkt’, dat na, yu laf ɔ kray, nɔ de mach yu ‘mud’, dat na, yu insay filin .

Lɛ wi ɛksplen dɛn kwaliti dɛn ya mɔ na di tebul we de dɔŋ ya.

Aw laf/krai kin apin na PBA Tɔk bɔt
Fɔ bi sɔntin we pɔsin kin du wantɛm wantɛm ɛn we i nɔ bin de ɛkspɛkt If yu nɔ wɔn yu , yu bigin fɔ laf ɔ kray wantɛm wantɛm. Yu nɔ go ebul fɔ kɔntrol dis.
Intɛnsity mismatch Ivin smɔl jok kin mek yu laf so tranga wan yu nɔ go ebul fɔ stɔp. Ivin smɔl tin we de mek yu at pwɛl kin mek yu kray fɔ lɔng tɛm. Dat min se di riakshɔn pas di tin we apin.
Nɔ gɛt rizin Sɔntɛnde, fɔ no rizin atɔl, yu kin laf ɔ kray lɛk dis, ivin we yu jɔs de bi yusɛf.

Sɔm pipul dɛn kin vɛks ɔ fil bad bak we dɛn nɔ ebul fɔ kɔntrol. Bikɔs PBA gɛt fɔ du wit ɔda nyurolɔjik kɔndishɔn, dɛn kin gɛt ɔda sayn dɛn bak we gɛt fɔ du wit da ɔndalayn kɔndishɔn de.

Wetin kin mek pɔsin gɛt PBA?

Wi nɔ stil no di rayt tin we kin mek pɔsin gɛt PBA, bɔt di dɔktɔ dɛn biliv se na bikɔs di nyurolɔjik rod dɛn na di bren we de kɔntrol aw pɔsin kin fil, kin ambɔg am.

Bɔku nyurolɔjik kɔndishɔn dɛn de we kin mek pɔsin gɛt dis sik. Dis min se pipul dɛm wae gɛt dɛn kayn tin ya kin de pan denja fɔ gɛt PBA.

  • Traumatik bren injuri
  • Amyotrophic lateral sclerosis (ALS) (dεn kin kכl am bak di sik we dεn kכl Lu Gehrig in sik) .
  • `Mɔltipɛl sklɛrosis (MS)`
  • Alzaima sik ɛn ɔda tin dɛm wae gɛt fɔ du wit dis maynia sik
  • Strok
  • Dis sik we dɛn kɔl Parkinson
  • Tumɔs dɛn na di bren
  • Epilepsy we pɔsin kin gɛt
  • Wilson in sik we dɛn kɔl Wilson

Us pat dɛn na di bren dis kin afɛkt?

Dɛn tink se dis sik kin afɛkt difrɛn pat dɛn na di bren. sכmtεm, i kin kכz fכ disrupshכn na di nyural path dεm we kכnekt to di sεribεl , we na wan pat pan di bren we de mכnitor di we aw wi de fil εn εp wi fכ disayd if dεn fit fכ wan soshal situeshכn.

Dɔn bak, dɛn tink se sɔm kemikal mɛsenja dɛn na di bren we dɛn kɔl nyurotransmitta dɛn de involv.

  • Serotonin we gɛt di sik
  • Norepinephrin `(Norepinephrine)`
  • Dopamin we dɛn kɔl Dopamin
  • Glutamɛt we dɛn kɔl
  • Asetilkolin `(Asetilkolin)`

Aw dɛn kin no se pɔsin gɛt PBA?

Fɔ no if pɔsin gɛt PBA kin tranga smɔl, bikɔs ivin dɔktɔ dɛn kin mistek no se i gɛt prɔblɛm wit di we aw pɔsin de fil lɛk pwɛl hat ɔ bipola muud .

Naw, no patikyula tɛst nɔ de fɔ kɔnfɔm if yu gɛt PBA. Dɔktɔ go no di sik afta i tek tɛm aks yu sɔm kwɛstyɔn dɛn.

  • Yu simptom dɛm
  • Yu mɛdikal histri, mɔ bɔt di nyurolɔjik kɔndishɔn
  • Yu mental hεlth histri
  • Infɔmeshɔn frɔm wan fyzikal ɛgzam

Wetin mek dɛn kin mistek kɔl PBA fɔ pwɛl hat?

Di men rizin we mek dɛn kɔnfyus di tu pipul dɛn na di kray we dɛn de kray. If kray na di men sayn fɔ PBA, bɔrku pipul kin tink se na pwɛl hat. Sɔmtɛm pɔrsin wae gɛt PBA kin gɛt pwɛl hat bak di sem tɛm. Bɔt klia difrɛns de bitwin di tu kɔndishɔn dɛn.

Si di tebul we de dɔŋ ya.

Di kwaliti we pɔsin gɛt Kray di tɛm we dɛn de du PBA Kray we yu gɛt pwɛl hat
Aw fɔ bigin I rili impɔtant fɔ du dat. I kin bigin wantɛm wantɛm. Bɔku tɛm, i kin bigin smɔl smɔl ɛn i kin go ɔp smɔl smɔl.
Ɔmɔs tɛm I kin jɔs las fɔ shɔt tɛm. I kin stɔp insay sɔm minit dɛn. I kin las fɔ lɔng tɛm.
Fɔ fil insay pɔsin in at Bɔku tɛm, no big sɔri-at nɔ de insay. Wans di kray dɔn stɔp, tin kin kam bak to nɔmal. I gɛt fɔ du wit dip sɔri-at we de te ɛn ɛmti tin we de insay pɔsin in at.
Ɔda tin dɛn we de apin Bɔrku tɛm, nɔrbɔdi nɔr kin chenj pan slip ɔr apɛtit. Ɔda sayn dɛm de lɛk wae yu nɔr de slip ɔr yu de slip pasmak, yu nɔr kin want fɔ it ɔr yu de it pasmak.

Tritmɛnt de fɔ PBA?

PBA nɔ go ebul fɔ mɛn ɔltogɛda. Bɔt dɛn kin ebul fɔ kɔntrol am fayn fayn wan . Di men gol fɔ tritmɛnt na fɔ ridyus di frɛkuɛns ɛn di kayn we aw dɛn kin laf ɔ kray.

Mɛrɛsin dɛn de we dɔktɔ dɛn kin advays fɔ dis.

  • Dextromethorphan/quinidine sulfate (Nuedexta®): Dis na di fɔs mɛrɛsin we di US FDA dɔn gri fɔ spɛshal fɔ trit PBA.
  • Di mɛrɛsin dɛn we de mek pɔsin nɔ fil bad:Sɔm mɛrɛsin wae de mek pɔrsin fil bad, lɛk trisayklik antidipreshan ɛn selektiv sɛrotonin riuptek inhibitor (SSRI), kin ɛp fɔ kɔntrol di PBA simptom dɛm, bɔt dɛn kin yuse dɛn pan bɔku smɔl dos dɛm pas di wan dɛm wae dɛn kin yuse fɔ pwɛl hat.

Impɔtant: Ɛni mɛrɛsin kin gɛt sayd ɛfɛkt, so yu fɔ rili tɔk to yu dɔktɔ fɔ no di bɛst tritmɛnt plan fɔ yu.

Aw yu de liv wit dis sityueshɔn?

If dɛn nɔ no ɛn trit PBA fayn, i kin afɛkt yu layf.

  • Pwɛl at
  • Wɔri
  • We di soshal rilayshɔnship wik
  • Di kwaliti fɔ layf we dɔn go dɔŋ

Bɔt mɛmba se dɛn kin kɔntrol dɛn sik ya fayn fayn wan wit mɛrɛsin. I kin tek sɔm tɛm fɔ gɛt di rayt diagnosis ɛn tritmɛnt. Bɔt yu fɔ tɔk fɔ yusɛf ɛn nɔ giv ɔp. Pipul dεm lεk nyurolכg εn saykayatrist dεm gεt mכr no bכt dis.

Tips fɔ bia wit PBA

Na sɔm tin dɛn ya we go ɛp yu fɔ kɔntrol dɛn tɛm ya we yu de laf ɔ kray.

  • We chans lɛk dis kam, tek dip briz sloslo te i pas .
  • Tink bɔt ɔda tin ɔ distɛkt yusɛf da tɛm de.
  • Rilaks yu sholda ɛn yu fes mɔsul dɛn. Dis go mek di tɛnsiɔn nɔ bɔku.
  • If i pɔsibul, chenj di we aw yu de tinap .
  • Tɛl pipul dɛn we yu kin trɔst bɔt yu sityueshɔn so dat dɛn go no wetin fɔ ɛkspɛkt.
  • If dis tin de afɛkt yu maynd, go to pɔsin we de gi advays bɔt yu maynd .

If yu gɛt PBA ɛn di tritmɛnt we yu de gi yu naw nɔ de wok ɔ de mek yu gɛt sayd ɛfɛkt, tɔk to yu dɔktɔ bɔt nyu tritmɛnt we yu go yuz. We pɔsin de laf ɛn kray we pɔsin nɔ ebul fɔ kɔntrol, i kin tranga ɛn i kin mek i shem. Bɔt mɛmba se PBA na mɛrɛsin, ɛn dɛn kin trit am wit mɛrɛsin. If yu gɛt dɛn sik ya, mek shɔ se yu go to dɔktɔ.

Mɛsej we dɛn kin kɛr go na os

  • Pseudobulbar affect (PBA) nכto mental sik, na nyurolכjik kכndishכn we de kכz bay ifekt pan di nεv path dεm na di bren.
  • Di laf ɔ kray we de kɔmɔt pan dis nɔ de mach yu insay filin. I at bak fɔ kɔntrol.
  • Bɔku tɛm, PBA kin gɛt fɔ du wit ɔda nyurolɔjik kɔndishɔn lɛk strok, MS, ALS, ɔ ed injuri.
  • Pan ɔl we dɛn kin mistek kɔl dis pwɛl hat, klia difrɛns de bitwin dɛn tu tin ya.
  • Tritmɛnt dɛn de we rili fayn fɔ kɔntrol dɛn sik ya. So nɔ shem ɔ fred, ɛn fɔ tru, go to dɔktɔ fɔ advays.

Pseudobulbar Affect, PBA, Laf we nɔ kin kɔntrol, kray we nɔ kin kɔntrol, Nyurolɔjik Disɔda, Bren Disɔda, Dipreshɔn

Frequently Asked Questions (FAQ)

Wetin mek dɛn kin mistek kɔl PBA fɔ pwɛl hat?

Di men rizin we mek dɛn kɔnfyus di tu pipul dɛn na di kray we dɛn de kray. If kray na di men sayn fɔ PBA, bɔrku pipul kin tink se na pwɛl hat. Sɔmtɛm pɔrsin wae gɛt PBA kin gɛt pwɛl hat bak di sem tɛm. Bɔt klia difrɛns de bitwin di tu kɔndishɔn dɛn.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 8 + 1 =
Yu de laf wantɛm wantɛm fɔ natin? Yu de kam kray? Dis kin bi Pseudobulbar Afɛkt (PBA) .

Yu de laf wantɛm wantɛm fɔ natin? Yu de kam kray? Dis kin bi Pseudobulbar Afɛkt (PBA) .

Imajin if yu jɔs sidɔm de, ɔ tɔk bɔt sɔntin we de mek yu at pwɛl smɔl, ɛn yu bigin fɔ laf lawd wan we yu nɔ ebul kɔntrol? Ɔ if yu bigin kray so dat yu nɔ go ebul fɔ stɔp ivin we yu jok smɔl? Pan ɔl we dis kin tan lɛk se i strenj smɔl, fɔ tru, na sik we pɔsin kin gɛt we i de mɛn pipul dɛn. Dis nɔto wikɛd tin na yu maynd ɔ sɔntin we kray. Tide wi de tɔk bɔt dis strenj, bɔt wan we kin afɛkt bɔku pipul dɛn.

Fɔ tɔk am simpul wan, wetin na Pseudobulbar Affect (PBA)?

Pseudobulbar affect (PBA) na wan kכndyushכn we de afekt di nεv sεstem. I kin bi se pɔsin nɔ ebul fɔ kɔntrol am, ɔ i nɔ fayn fɔ laf ɔ kray. Di impɔtant tin na fɔ mek dis laf ɔ kray nɔ gri wit di we aw yu de fil insay yu at . Dis min se yu kin kray we yu nɔ ebul fɔ kɔntrol yusɛf ilɛksɛf yu nɔ de fil bad insay yu at. Semweso, yu kin laf we yu nɔ ebul kɔntrol ilɛksɛf natin nɔ de fɔ laf.

Dis kכndyushכn kin apin as a rizulεt fכ damej pan di bren כ as sayd ifekt fכ כda nyurolכjik kכndyushכn. fכ egzampl, yu kin si am wit wan kכndishכn lεk `(Amyotrophic Lateral Sclerosis - ALS)`.

Pan ɔl we sɔmtɛm dis laf ɔ kray kin tan lɛk se i fayn da tɛm de (fɔ ɛgzampul, fɔ kray we yu si sɔntin we sɔri), i kin rili at fɔ mek pɔsin we gɛt PBA kɔntrol am. Ɛn di we aw dɛn de sho dɛn filin ya kin rili tranga ɛn i kin te pas aw pɔsin kin fil.

Dɛn kin kɔl dis kɔndishɔn sɔm ɔda nem dɛn:

  • Imɔshɔnal labiliti
  • Pathological laf ɛn kray
  • Dizayd fɔ sho aw pɔsin de fil we i nɔ want
  • Fɔ laf ɔ kray we pɔsin kin fos fɔ du
  • I nɔ kin ebul fɔ kɔntrol insɛf pan di we aw pɔsin de fil

PBA kin rili afɛkt yu layf, yu famili, ɛn di wan dɛn we de kia fɔ yu. I kin mek pɔsin shem, wɔri, fɔ lɛf fɔ it, ɛn ivin fɔ mek i nɔ de nia ɔda pipul dɛn.

Aw kɔmɔn dis kɔndishɔn, PBA? Udat kin gɛt am?

E tranga fɔ tɔk ustɛm dis kin bi, bikɔs de kayn sik wae de kam pan dis sik kin difrɛn frɔm pɔrsin to ɔda pɔrsin. Dɔn bak, bɔrku tɛm dɛn kin misdiagnose am as ɔda sik, mɔr lɛk pwɛl hat.

PBA kin apin pan ɛnibɔdi we gɛt ɛni ej, ivin pikin ɛn big pipul, we gɛt ɔda sik we gɛt fɔ du wit dɛn bren.

As di mɛdikal stɔdi dɛn dɔn sho:

  • כp to 50% pan di pipul dεm we gεt amyotrophic lateral sclerosis (ALS) kin gεt PBA.
  • Dis kכndyushכn kin apun to 48% pan di pipul dεm wae dεn gεt traumatik bren injuri.
  • te to 46% pan di pipul dεm we gεt mכltipכl sklεrosis (MS) kin gεt PBA.

So yu tink se dis na mental sik?

Bɔrku pipul kin tink bɔt am as maynd sik bikɔs na do kin gɛt fɔ du wit filin lɛk fɔ laf ɛn kray. Bɔt fɔ tru, i nɔto mental sik atɔl.

Fɔ tɔk strikt wan, PBA na nyurosaykayatrik sindrom . Fɔ tɔk am simpul wan, na kɔndishɔn we yu nɔ kin ebul fɔ kɔntrol yu filin bikɔs di nyural sɔrkwit dɛn na yu bren dɔn pwɛl. So e kin kɔrɛkt fɔ tink bɔt am as bɔdi prɔblɛm we gɛt fɔ du wit di bren pas fɔ tink bɔt am as prɔblɛm wit yu maynd.

Wetin na di men sayn dɛm fɔ PBA?

fכ כndastand PBA, wi nid fכ no di difrεns bitwin ‘mud’ εn ‘afεkt’.

  • Di we aw yu de fil: Dis de tɔk bɔt aw yu de fil insay yu at. Dat min se di filin dɛn we yu kin fil insay yu at, lɛk fɔ fil bad, fɔ gladi, ɛn fɔ vɛks. Dis na sɔntin we na yu nɔmɔ go ebul fɔ fil.
  • Affect: Dis na aw yu de sho aw yu de fil na do. Dat min tin dɛn lɛk fɔ smayl, kray, ɛn fɔ sho aw ɔda pipul dɛn de si in fes.

So, di men tin we PBA gɛt na dat yu ‘afɛkt’, dat na, yu laf ɔ kray, nɔ de mach yu ‘mud’, dat na, yu insay filin .

Lɛ wi ɛksplen dɛn kwaliti dɛn ya mɔ na di tebul we de dɔŋ ya.

Aw laf/krai kin apin na PBA Tɔk bɔt
Fɔ bi sɔntin we pɔsin kin du wantɛm wantɛm ɛn we i nɔ bin de ɛkspɛkt If yu nɔ wɔn yu , yu bigin fɔ laf ɔ kray wantɛm wantɛm. Yu nɔ go ebul fɔ kɔntrol dis.
Intɛnsity mismatch Ivin smɔl jok kin mek yu laf so tranga wan yu nɔ go ebul fɔ stɔp. Ivin smɔl tin we de mek yu at pwɛl kin mek yu kray fɔ lɔng tɛm. Dat min se di riakshɔn pas di tin we apin.
Nɔ gɛt rizin Sɔntɛnde, fɔ no rizin atɔl, yu kin laf ɔ kray lɛk dis, ivin we yu jɔs de bi yusɛf.

Sɔm pipul dɛn kin vɛks ɔ fil bad bak we dɛn nɔ ebul fɔ kɔntrol. Bikɔs PBA gɛt fɔ du wit ɔda nyurolɔjik kɔndishɔn, dɛn kin gɛt ɔda sayn dɛn bak we gɛt fɔ du wit da ɔndalayn kɔndishɔn de.

Wetin kin mek pɔsin gɛt PBA?

Wi nɔ stil no di rayt tin we kin mek pɔsin gɛt PBA, bɔt di dɔktɔ dɛn biliv se na bikɔs di nyurolɔjik rod dɛn na di bren we de kɔntrol aw pɔsin kin fil, kin ambɔg am.

Bɔku nyurolɔjik kɔndishɔn dɛn de we kin mek pɔsin gɛt dis sik. Dis min se pipul dɛm wae gɛt dɛn kayn tin ya kin de pan denja fɔ gɛt PBA.

  • Traumatik bren injuri
  • Amyotrophic lateral sclerosis (ALS) (dεn kin kכl am bak di sik we dεn kכl Lu Gehrig in sik) .
  • `Mɔltipɛl sklɛrosis (MS)`
  • Alzaima sik ɛn ɔda tin dɛm wae gɛt fɔ du wit dis maynia sik
  • Strok
  • Dis sik we dɛn kɔl Parkinson
  • Tumɔs dɛn na di bren
  • Epilepsy we pɔsin kin gɛt
  • Wilson in sik we dɛn kɔl Wilson

Us pat dɛn na di bren dis kin afɛkt?

Dɛn tink se dis sik kin afɛkt difrɛn pat dɛn na di bren. sכmtεm, i kin kכz fכ disrupshכn na di nyural path dεm we kכnekt to di sεribεl , we na wan pat pan di bren we de mכnitor di we aw wi de fil εn εp wi fכ disayd if dεn fit fכ wan soshal situeshכn.

Dɔn bak, dɛn tink se sɔm kemikal mɛsenja dɛn na di bren we dɛn kɔl nyurotransmitta dɛn de involv.

  • Serotonin we gɛt di sik
  • Norepinephrin `(Norepinephrine)`
  • Dopamin we dɛn kɔl Dopamin
  • Glutamɛt we dɛn kɔl
  • Asetilkolin `(Asetilkolin)`

Aw dɛn kin no se pɔsin gɛt PBA?

Fɔ no if pɔsin gɛt PBA kin tranga smɔl, bikɔs ivin dɔktɔ dɛn kin mistek no se i gɛt prɔblɛm wit di we aw pɔsin de fil lɛk pwɛl hat ɔ bipola muud .

Naw, no patikyula tɛst nɔ de fɔ kɔnfɔm if yu gɛt PBA. Dɔktɔ go no di sik afta i tek tɛm aks yu sɔm kwɛstyɔn dɛn.

  • Yu simptom dɛm
  • Yu mɛdikal histri, mɔ bɔt di nyurolɔjik kɔndishɔn
  • Yu mental hεlth histri
  • Infɔmeshɔn frɔm wan fyzikal ɛgzam

Wetin mek dɛn kin mistek kɔl PBA fɔ pwɛl hat?

Di men rizin we mek dɛn kɔnfyus di tu pipul dɛn na di kray we dɛn de kray. If kray na di men sayn fɔ PBA, bɔrku pipul kin tink se na pwɛl hat. Sɔmtɛm pɔrsin wae gɛt PBA kin gɛt pwɛl hat bak di sem tɛm. Bɔt klia difrɛns de bitwin di tu kɔndishɔn dɛn.

Si di tebul we de dɔŋ ya.

Di kwaliti we pɔsin gɛt Kray di tɛm we dɛn de du PBA Kray we yu gɛt pwɛl hat
Aw fɔ bigin I rili impɔtant fɔ du dat. I kin bigin wantɛm wantɛm. Bɔku tɛm, i kin bigin smɔl smɔl ɛn i kin go ɔp smɔl smɔl.
Ɔmɔs tɛm I kin jɔs las fɔ shɔt tɛm. I kin stɔp insay sɔm minit dɛn. I kin las fɔ lɔng tɛm.
Fɔ fil insay pɔsin in at Bɔku tɛm, no big sɔri-at nɔ de insay. Wans di kray dɔn stɔp, tin kin kam bak to nɔmal. I gɛt fɔ du wit dip sɔri-at we de te ɛn ɛmti tin we de insay pɔsin in at.
Ɔda tin dɛn we de apin Bɔrku tɛm, nɔrbɔdi nɔr kin chenj pan slip ɔr apɛtit. Ɔda sayn dɛm de lɛk wae yu nɔr de slip ɔr yu de slip pasmak, yu nɔr kin want fɔ it ɔr yu de it pasmak.

Tritmɛnt de fɔ PBA?

PBA nɔ go ebul fɔ mɛn ɔltogɛda. Bɔt dɛn kin ebul fɔ kɔntrol am fayn fayn wan . Di men gol fɔ tritmɛnt na fɔ ridyus di frɛkuɛns ɛn di kayn we aw dɛn kin laf ɔ kray.

Mɛrɛsin dɛn de we dɔktɔ dɛn kin advays fɔ dis.

  • Dextromethorphan/quinidine sulfate (Nuedexta®): Dis na di fɔs mɛrɛsin we di US FDA dɔn gri fɔ spɛshal fɔ trit PBA.
  • Di mɛrɛsin dɛn we de mek pɔsin nɔ fil bad:Sɔm mɛrɛsin wae de mek pɔrsin fil bad, lɛk trisayklik antidipreshan ɛn selektiv sɛrotonin riuptek inhibitor (SSRI), kin ɛp fɔ kɔntrol di PBA simptom dɛm, bɔt dɛn kin yuse dɛn pan bɔku smɔl dos dɛm pas di wan dɛm wae dɛn kin yuse fɔ pwɛl hat.

Impɔtant: Ɛni mɛrɛsin kin gɛt sayd ɛfɛkt, so yu fɔ rili tɔk to yu dɔktɔ fɔ no di bɛst tritmɛnt plan fɔ yu.

Aw yu de liv wit dis sityueshɔn?

If dɛn nɔ no ɛn trit PBA fayn, i kin afɛkt yu layf.

  • Pwɛl at
  • Wɔri
  • We di soshal rilayshɔnship wik
  • Di kwaliti fɔ layf we dɔn go dɔŋ

Bɔt mɛmba se dɛn kin kɔntrol dɛn sik ya fayn fayn wan wit mɛrɛsin. I kin tek sɔm tɛm fɔ gɛt di rayt diagnosis ɛn tritmɛnt. Bɔt yu fɔ tɔk fɔ yusɛf ɛn nɔ giv ɔp. Pipul dεm lεk nyurolכg εn saykayatrist dεm gεt mכr no bכt dis.

Tips fɔ bia wit PBA

Na sɔm tin dɛn ya we go ɛp yu fɔ kɔntrol dɛn tɛm ya we yu de laf ɔ kray.

  • We chans lɛk dis kam, tek dip briz sloslo te i pas .
  • Tink bɔt ɔda tin ɔ distɛkt yusɛf da tɛm de.
  • Rilaks yu sholda ɛn yu fes mɔsul dɛn. Dis go mek di tɛnsiɔn nɔ bɔku.
  • If i pɔsibul, chenj di we aw yu de tinap .
  • Tɛl pipul dɛn we yu kin trɔst bɔt yu sityueshɔn so dat dɛn go no wetin fɔ ɛkspɛkt.
  • If dis tin de afɛkt yu maynd, go to pɔsin we de gi advays bɔt yu maynd .

If yu gɛt PBA ɛn di tritmɛnt we yu de gi yu naw nɔ de wok ɔ de mek yu gɛt sayd ɛfɛkt, tɔk to yu dɔktɔ bɔt nyu tritmɛnt we yu go yuz. We pɔsin de laf ɛn kray we pɔsin nɔ ebul fɔ kɔntrol, i kin tranga ɛn i kin mek i shem. Bɔt mɛmba se PBA na mɛrɛsin, ɛn dɛn kin trit am wit mɛrɛsin. If yu gɛt dɛn sik ya, mek shɔ se yu go to dɔktɔ.

Mɛsej we dɛn kin kɛr go na os

  • Pseudobulbar affect (PBA) nכto mental sik, na nyurolכjik kכndishכn we de kכz bay ifekt pan di nεv path dεm na di bren.
  • Di laf ɔ kray we de kɔmɔt pan dis nɔ de mach yu insay filin. I at bak fɔ kɔntrol.
  • Bɔku tɛm, PBA kin gɛt fɔ du wit ɔda nyurolɔjik kɔndishɔn lɛk strok, MS, ALS, ɔ ed injuri.
  • Pan ɔl we dɛn kin mistek kɔl dis pwɛl hat, klia difrɛns de bitwin dɛn tu tin ya.
  • Tritmɛnt dɛn de we rili fayn fɔ kɔntrol dɛn sik ya. So nɔ shem ɔ fred, ɛn fɔ tru, go to dɔktɔ fɔ advays.

Pseudobulbar Affect, PBA, Laf we nɔ kin kɔntrol, kray we nɔ kin kɔntrol, Nyurolɔjik Disɔda, Bren Disɔda, Dipreshɔn

Frequently Asked Questions (FAQ)

Wetin mek dɛn kin mistek kɔl PBA fɔ pwɛl hat?

Di men rizin we mek dɛn kɔnfyus di tu pipul dɛn na di kray we dɛn de kray. If kray na di men sayn fɔ PBA, bɔrku pipul kin tink se na pwɛl hat. Sɔmtɛm pɔrsin wae gɛt PBA kin gɛt pwɛl hat bak di sem tɛm. Bɔt klia difrɛns de bitwin di tu kɔndishɔn dɛn.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 8 + 1 =